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ABSTRACT 
 
Direct Interaction of Rotavirus Non Structural Protein 4 with Heat Shock Protein 56 
Protein. (May 2012) 
 
Soon Young Moon 
Department of Biology 
Texas A&M University 
 
Research Advisor: Dr. Judith Ball 
Department of Virology 
 
Rotavirus (RV) causes more than 2 million diarrhea incidents and more than 600,000 
deaths around the world every year. In order to prevent and treat this fatal disease, we 
must study, in depth, the mechanisms and pathogenesis of the individual viral proteins.  
It is known that RV non-structural protein 4 (NSP4) binds to several host-cell proteins, 
including cycophilin A and 40, which are immunophilins. In this study, we will 
specifically study another immunophilin/chaperone protein, Heat Shock Protein 56 
(FKBP4). Previous studies suggest that FKBP4 plays an important role in transporting 
cholesterol from the ER to caveolae. During this study, we will use the yeast 2-hybrid 
assay (Y2H) to ascertain direct binding between NSP4 and FKBP4. After completion of 
this project, FKBP4 may be interacting weakly or does not interact with NSP4. 
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NOMENCLATURE 
 
Cav-1 Caveolin-1 
CypA Cyclophilin A 
Cyp40 Cycolophilin 40 
CPRG Chlorophenol Red Beta D-Galactopyranoside 
FKBP4  Heat Shock Protein 56 
HSP 56 Heat Shock Protein 56 
NSP4 Non-Structural Glycoprotein 4 
RED Restriction Enzyme Digestion 
RV Rotavirus 
Y2H Yeast 2-Hybrid 
MID1IP1 Mid 1 Interacting Protein 1 
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CHAPTER I 
INTRODUCTION 
 
Rotavirus (RV) 
 
Rotavirus (RV) is a major cause of viral gastroenteritis in children, the elderly and 
immunocompromised patients. Annually, RV causes more than 2 million diarrhea 
incidents and more than 600,000 deaths around the world. Although much is known 
about the epidemiologoy and genetics of RV, further understanding of RV-induced fluid 
loss is needed to reduce RV mortality and morbidity. To enhance the knowledge of the  
mechanisms by which RV infection affects the host, we will determine how the RV 
enterotoxin, NSP4, traffics to the plasma membrane by determining  which host-cell 
proteins are directly interacting with NSP4 and contributing to this trafficking event. We 
will use the yeast two-hybrid assay to determine if NSP4 is directly interacting with 
specific cellular proteins. 
  
RV consists of a triple layered protein coat encasing 11 strands of double stranded RNA 
(dsRNA) that code for 12 proteins. The complete virion, the triple layer particle (TLP), 
is infectious. The spike protein, viral protein 4 (VP4), is cleaved by intestinal proteases 
to activate the virus and allow attachment of the virus to sialic acid and other receptors 
and co-receptors on intestinal epithelial cells to enter the cell. (Estes) Once  
 
______________ 
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the virus enters the cell, the low calcium environment of the cytoplasm causes the outer 
layer,composed of VP7, to disassociate and the virus becomes a double layered particle  
(DLP). This double-layered particle is transcriptionally active, but not infectious because  
it lacks the receptor molecule that allows RV to enter the cell. Once in the cytoplasm, the 
dsRNA genome of RV is transcribed into mRNA within the DLP.  The mRNA exits the 
DLP through specific DLP channels and travels to ribosomes to be translated into viral 
proteins.  Most of the viral proteins aggregate into a replication center near the ER called 
the viroplasm. It is here that the enterotoxin NSP4 plays its first major role in RV 
pathogenesis. (Cubitt 1980 and Holzel, Jayaram et al 1980) 
 
NSP4 
NSP4 is encoded by RV gene 10, is translated by ER membrane bound ribosomes, and is 
co-translationally inserted into the ER membrane.  Traditionally, it has become known 
as a resident ER glycoprotein.  NSP4 traverses the ER membrane such that a short N-
terminal region is in the ER lumen and an extended C-terminal domain extends into the 
cytosol.  There is a binding site in the C-terminus that attaches to VP6 (middle layer 
protein) in the viroplasm and recruits the DLP into the ER.  Ca++-dependent VP7 is 
added in the ER and possibly the VP4 spike protein to complete viral maturation. (Ball 
1996, Cohen et al 1979) NSP4 then travels from the ER to the plasma membrane via an 
unconventional trafficking pathway that bypasses the Golgi. It has been shown that 
NSP4 binds to several host-cell proteins, including tubulin, caveolin-1, cholesterol, 
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cyclophilin A, cyclophilin 40 and HSP56, which may contribute to NSP4 secretory 
transport.  
NSP4 also is released from cells early post infection, giving it access to surface 
receptors. Thus, in addition to playing a key role in RV morphogenesis, NSP4 induces 
diarrhea by itself when bound to surface molecules.  Purified NSP4 or peptides 
administered intraperitoneally (IP) to mouse pups induces Cl- secretion from cells via a 
calcium-mediated pathway. NSP4 also plays key role in the immune response.  Hence, 
NSP4 is a multifunctional protein that has distinct properties when expressed inside the 
cell and when secreted. (Ball 1996, Taylor and Bellamy 2003) 
 
Caveolin chaperone complex and FKBP4 
The caveolin chaperone complex (CCC) is a complex consisting of several proteins that 
plays an important role in transporting cholesterol from the ER to caveolae 
microdomains on the plasma membrane. Previous studies showed that the CCC consists 
of heat shock protein 56 (FKBP4), caveolin-1 (cav-1), cyclophilin 40 (cyp40), 
cyclophilin A (cypA), and cholesterol. Studies in Dr. Judith Ball’s lab have shown that 
NSP4 directly binds with caveolin-1 using immunoprecipitation and yeast two-hybrid 
assays (Parr et al 1996). We reported that NSP4 and peptides preferentially bind highly 
curved, cholesterol-rich model membranes that resemble caveolae. (Schroeder 2001) We 
then isolated NSP4 from caveolae fractions acquired from infected cells (Parr 2006).  
Our recent data shows that NSP4 directly binds to cholesterol (Schroeder, 2011). Taken 
together, we have shown an interaction between NSP4 and, caveolin-1 (cav-1), 
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cyclophilin 40 (cyp40), cyclophilin A (cypA) and cholesterol. Other labs have found 
additional binding partners for NSP4. (Gibbons, 2011). We were unable to discern the 
binding of NSP4 to FKBP4 due to the lack of a reactive antibody. Thus we propose to 
determine if NSP4 directly binds to FKBP4 using the Yeast 2 Hybrid (Y2H) system.  
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CHAPTER II 
METHODS 
 
In order to study protein-protein interactions, we used the Pro Quest Y2H method. In 
order to perform Y2H, first we must isolate, amplify and identify the proper gene of 
interest (in this experiment NSP4 and FKBP4). Then we must transform the yeast with 
these genes linked to the activating domain of GAL4 (FKBP4) and the binding domain 
of GAL4 (NSP4). If the two proteins interact, the activating and binding domains will be 
brought together, the yeast will recruit transcription factors to the  GAL4 binding site 
and transcription will occur.  If the 2 proteins fail to interact, the activating and binding 
domains will remain separated and transcription will not occur. As yeast transcribe the 
genes, leucine, tryptophan or various reporter genes, such as LacZ, HIS3, URA3, will be 
expressed depending on the protein:protein interaction level. We will analyze various 
plates that are missing the appropriate amino acids, that are supposed to be expressed by 
yeast, to qualitatively observe the protein:protein interactions. In order to quantify the 
strength of the interaction, we will utilize the CPRG technique.  
 
Designing the vector  
We purchased a plasmid containing the FKBP4 sequence from OriGene, pCMV6-XL5-
FKBP4. The plasmid was made with a CMV promoter, and has the gene of interest 
cloned between two Not1 sites. The FKBP4 gene was cloned into a Gateway entry 
vector, pENTR11 (Invitrogen) by cutting the FKBP4 gene out of the plasmid Pcmv6-
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XL5-FKBP4 using FastDigest enzymes (fermentas), BamHI, XhoI and XmnI. After 
running a restriction enzyme digestion (RED), the samples were run in 1% agrose gel. 
We then isolated a fragment corresponding to the  correct size of our gene of interest 
using UltraClean GelSpinKit (MoBio). After we isolated the gene it was amplified via 
PCR and then it inserted into pENTR11 with T4 ligase. The ligation was checked using 
another RED and running a gel. Once we established that the the entry vector was 
correct, we amplified the gene using E. coli transformation. The same protocol was 
followed for NSP4. 
 
E. coli transformation 
We individually transformed these plasmids into competent E coli that we purchased 
(DH5alpha). Competent E coli will take up the surrounding plasmid. In this experiment 
we transformed with NSP4 and FKBP4. Transformation of the plasmids was aided by 
heat shock and incubating at 37 degrees with shaking  overnight. We pellet the cells and 
isolated the plasmid using a miniprep isolation kit. To check for the correct plasmid, we 
utilized the RED technique.  FastDigest enzymes (Fermentas) were used in this 
experiment. Bam HI, EcoRV, HindIII was used for NSP4, while BamHI, XhoI and 
XmnI was used for FKBP4. After RED, the samples were run in a 1% agrose gel. Based 
on the fragment sizes we can identify whether or not our gene was transformed correctly.  
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Recombination of plasmid to proper vector 
Both entry level plasmids, NSP4 and FKBP4, were ready to examine by Y2H using the 
destiny vectors PDEST22 and pDEST32 respectively. The destiny vectors PDEST22 and 
pDEST32 contain the gene for leucine and tryptophan, respectively, and both contain 
reporter genes (HIS3, URA3 and lacZ).  The LR Clonase enzyme kit was used for the 
recombination. The recombination was checked by restriction enzyme digestion and then 
to ensure that we have the correct sequence, the sample was sequenced at the Texas 
A&M University core laboratory and cross-checked with the sequence that was provided 
by the company. 
 
Y2H 
After the genes were cloned into the proper vector, they were transformed into yeast. As 
we mentioned earlier, each construct contained a gene that expressed a specific amino 
acid when the yeast translated the plasmid. Thus only correctly transformed yeast can 
grow on the plate with deficient media that was  prepared without the specific amino 
acids. Table 1 set up we used. 
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Table 1 Transformation Setup 
Transformation Plasmid 1 Plasmid 2 Plate Purpose 
1 pDBLeu  None SC-Leu Transformation control 
2 None None SC-Leu, SC-Leu, -Trp 
Negative 
transformational 
control 
3 pDBLeu Pexp-AD502 SC-Leu, -Trp Self activation control 
4 pD32 FKBP4 Pexp-AD502 SC-Leu, -Trp Self activation of PDEST32 
5 pDBLeu pD22-NSP4 SC-Leu, -Trp Self activation of pD22-NSP4 
6 pD32 FKBP4 pD22-NSP4 SC-Leu, -Trp 
Interaction test 
for pD32-
FKBP4 and 
pD22-NSP4 
7 pD32 FKBP4 None SC-Leu Transformational control 
pDBLeu is plasmid provided by company that allows yeast to express leucine 
Pexp-AD502 is plasmid provided by company that allows yeast to express tryptophan 
SC=Synthetic Complete Medium  
 
 
 
Qualifying a protein protein interaction 
After the colonies grow in plate 6, which is testing the protein protein interaction 
between NSP4 and FKBP4, is grown in various plates to determine how strong of 
interaction these proteins are by comparing with controls that were provided by 
company that contains either two interaction protein or two proteins that do not interact 
(Control A,B,C,D,E; A has no interaction, E have very strong interaction). Also utilizing 
reporter gene we can eliminate false positive because these expression require 
interaction of two proteins in order to be expressed.   
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When HIS3 is activated, yeast will produce imidazole glycerol phosphate dehydratase 
that allows histidine biosynthesis. But 3AT (3 Amino 1,2,4 Triazole) is an inhibitor of 
this enzyme. Thus stronger the two protein interacts; more growth of yeast on a plate 
that lacks histidine will be observed. As concentration of 3AT increase, we should see 
less growth. 
 
When URA3 is activated, yeast will synthesize uracil, thus only when two proteins 
interact, there will be a growth on a plate. Also when URA3 is activated, yeast convert 
5FOA (5 fluorooratic acid) to 5 fluorouracil, which is toxic. Thus stronger the interaction 
of two proteins, less growth is observed in 5FOA plate. 
When lacZ is activated, yeast will express beta galactosidase. Thus when we run X-Gal 
(5-bromo-4-chloro-indolyl-β-D-galactopyranosid) assay, colonies will change color to 
blue if positive. X-Gal assay is completely by lysing the yeast by repeating freeze-
thawing, and adding X-Gal solution to observe color change. 
After qualitatively observe the protein protein interactions, we have to quantify our data. 
  
Quantifying protein protein interaction 
To quantify, we used CPRG (Chlorophenol red D galactopyranoside) technique. CPRG 
act as a substrate to beta glycosidase that is expressed by the yeast if there was protein 
protein interaction. Using time and precipitation observed using spectrophotometer, we 
can calculate how much of beta galactosidase unit is present, which allows us to 
determines whether interaction is weak, moderate or strong. 
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CHAPTER III 
RESULTS 
 
Y2H with NSP4 and Cav1 
We know from our previously reported data that NSP4 interacts with Cav1 by Y2H (Parr 
2006). Consequently, this interaction was utilized to develop the necessary reagents and 
techniques to evaluate NSP4 with heat shock protein 56 (hsp56) using Cav1 as the 
positive control. Both the NSP4 and Cav1 plasmids previously were constructed, so 
learning and utilization of the technique was pursued .  Individual transformation of the 
yeast with the controls, NSP4 and Cav1 was successful. We verified the transformation 
success by additional controls in which we have set up. In this experiment, yeast (S. 
cerevisiae MAV203 strand) was genetically modified by the company yeast requires all 
essential amino acids in order to grow. To take advantage of this characteristic, we set up 
our experiments with various plasmids that allow yeast to express the missing or deleted 
amino acid(s) to test transformation success.  
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Table 2 Transformation Controls of NSP4 and Cav1 
Transformation Plasmid 1 Plasmid 2 Plate Purpose Results 
1 pDBLeu  None SC-Leu Transformation control 
Growth 
2 None None 
SC-Leu, 
SC-Leu, 
-Trp 
Negative 
transformational 
control 
No growth 
3 pDBLeu Pexp-AD502 
SC-Leu, 
-Trp 
Self activation 
control 
Growth 
4 pD32 Cav1 
Pexp-
AD502 
SC-Leu, 
-Trp 
Self activation of 
PDEST32 
Growth 
5 pDBLeu pD22-NSP4 
SC-Leu, 
-Trp 
Self activation of 
pD22-NSP4 
Growth 
6 pD32 Cav1 
pD22-
NSP4 
SC-Leu, 
-Trp 
Interaction test 
for pD32-
FKBP4 and 
pD22-NSP4 
Growth 
7 pD32 Cav1 None SC-Leu 
Transformational 
control 
Growth 
In Table 2, transformation 1 was set as the transformation control. The yeast was 
transformed with the pDBLeu plasmid, which is a necessary gene for yeast to synthesize 
Leucine (leu) amino acid. We plated the yeast in transformation 1 in complete synthetic 
(SC) media without leu. Thus if transformation was successful and the yeast expressed 
the pDBLeu gene, then these yeast will synthesize leu and demonstrate growth in the 
plate that lacks leu. After incubating for 96 hours, growth was present. This confirmed 
success in transformation. Transformation 2 was the negative control. We transformed 
yeast with no plasmid, then plated in SC without leu and SC without leu and tryptophan 
(trp). Due to the lack of essential amino acids that are required for yeast growth, there 
should not be any growth, and there was no growth after 96 hours of incubation. 
Transformation 3 was the positive control. The yeast were transformed with pDBLeu 
and Pexp-AD502 plasmids, which are necessary genes for yeast to synthesize leu and trp 
  12 
amino acids, respectively. We plated transformation 3 yeast in SC media that lacked leu 
and trp. Thus if transformation was successful and the yeast expressed pDBLeu and 
Pexp-AD502 gene, then yeast will synthesize leu and trp and show growth in the plate 
that lacks leu and trp. After incubating for 96 hours, growth was present. This confirmed 
success in transformation. Transformation 4 was set up to test the activation of pD32 
Cav1. The vector pD32 contains a gene that expresses leu, and we recombined this 
vector with the Cav1 gene. If plasmid pD32 Cav1 was transformed successfully, the 
yeast will synthesize leu as well as express Cav1. The yeast was transformed with the 
pD32 Cav1 and Pexp-AD502 plasmids. We plated transformation 4 yeast in SC media 
without leu and trp. Thus if transformation was successful and yeast expressed pD32 
Cav1 and the Pexp-AD502 gene, then yeast will synthesize leu and trp and show growth 
in the plate that lacks leu and trp. After incubating for 96 hours, growth was present as 
anticipated. This confirmed success in transformation. Transformation 5 was a self 
activation test. The yeast were transformed with pDBLeu and pD22 NSP4. The vector 
pD22 contains the gene that expresses trp, and we recombined it with this vector 
encoding the NSP4 gene. If plasmid pD22 NSP4 was transformed successfully, the yeast 
will synthesize trp.  We plated transformation 5 yeast in SC media without leu and trp. 
Thus if transformation was successful and the yeast expressed pDBLeu and pD22 NSP4 
genes, then the yeast will synthesize leu and trp and  permit growth in the plates that 
lacks leu and trp. After incubating for 96 hours, growth was present. These results again 
confirmed success in transformation. Transformation 6 evaluated the interaction between 
Cav1 and NSP4. Yeast were transformed with pD32 Cav1 and pD22 NSP4. If the 
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transformation was successful, the yeast should synthesize leu and trp and demonstrate 
growth in the plate that lacks leu and trp. After incubating for 96 hours, growth was 
present. This confirmed success in transformation. 
 
In the final transformation control, transformation 7, yeast was transformed with pD32 
Cav1 plasmid which includes a necessary gene for yeast to synthesize leu amino acid. 
We plated transformation 7 yeast in SC media without leu. Thus if transformation was 
successful and yeast expressed then pD32 Cav1 gene, then yeast will synthesize leu and 
there will be growth in the plate that lacks leu. After incubating for 96 hours, growth was 
present. This confirmed success in transformation. 
 
Interaction controls 
Controls A, B, C, D, and E were provided by the company that have different interaction 
strengths. As shown in Table 3, Control A has no interaction and the interaction 
strengths increase as we go to Control E, which has very strong interaction. 
 
Table 3 Interaction Controls  
Control Strain Interaction Strength 
A None 
B Weak 
C Moderately Strong 
D Strong 
E Very Strong 
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Controls A, B, C, D, E were plated with transformation 5 and 6 yeast grown from 
previous steps onto the following media plates: SC that lacks leu, trp, and histamine (his) 
but contains 3AT (We tested three concentrations, 12.5mM, 50mM and 100 mM), SC 
that lacks leu, trp, and uracil (ura), SC that lacks leu, trp, but contains 0.2% 5 
fluoroorotic acid (5FOA), and Yeast Extract - Peptone - Dextrose plus Adenine medium 
(YPAD). These medias are used to obtain qualitative data as well as to test for the 
presence of false positives. Each gene is recombined with the activating and binding 
domains. For example pD22 includes the binding domain while pD32 includes the 
activating domain. Only when the two protein interact will the activating and binding 
domains recruit the transcription factors that allow expression of the three reporter genes 
(his3, ura3, and lacZ). Thus, if the two proteins interact, the yeast will express the his3 
gene and synthesize his. Thus when yeasts are plated in SC that lacks leu, trp, and his, 
but contains 3AT, there will be growth since the activating and binding domains recruit 
transcription factors and express his. 3AT is a his inhibitor, thus the higher the 3AT 
concentration, the greater the inhibition, and the lower the growth should be observed.  
These plates are utilized to establish a basal expression level and eliminate false 
positives. If the proteins do not interact, there will be no growth. If the two proteins 
interact, yeast also will express the ura3 gene, enabling the synthesis of ura. To test 
expression of ura3, we plated yeast in SC that lacks leu, trp, and ura. If there was 
expression of the Ura3 gene, there will be growth. Uracil tends to convert (5FOA) to 5 
fluorouracil, an analog of thymine that inhibits dTMP synthase and kills the cells. Thus 
if yeast that express the ura3 gene is plated in SC that lacks leu, trp, but contains 0.2% 
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5FOA, there should be no growth. If there is no expression of the ura3 gene, then there is 
no conversion of 5FOA to 5fluorouracil.  
 
The YPAD plate contains all the necessary nutrients and amino acids, so all of the yeast 
should grow in YPAD. Colonies that grew on YPAD was used for X gal assay and 
CRPG assay. If plate SC lacks leu, trp, and his but contains 12.5mM 3AT, then controls 
A and B will have no growth, but controls C and D would have little growth, while E 
would have a lot of growth. Transformation 5 and 6 both should have growth in controls 
D and E. In SC that lacks leu, trp, and his, but contains 50mM 3AT, controls A, B 
showed no growth,  controls C and D showed little growth (less than 12.5mM 3AT),  
while control E had a lot of growth. Transformation 5 and 6 both had growth between 
controls D and E. In SC that lacks leu, trp, and his, but contains 100mM 3AT, controls 
A, B showed no growth,  controls C and D showed little growth (less than 50mM 3AT),  
while control E had a lot of growth. Transformation 5 and 6 both had growth between 
controls D and E.  
 
In SC that lacks leu, trp, and ura, controls A and B have no growth, but C and D have 
little growth, while E has a lot of growth. Transformation 5 and 6 both had growth 
equivalent to control C.  
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SC that lacks leu, trp, but contains 0.2% 5 fluoroorotic acid (5FOA), controls A, and B 
have the most growth, but C and D has little growth, while E has no growth. 
Transformation 5 and 6 both had growth equivalent to that of D.  
In YPAD plate, every sample had great growth. To this plate, we performed 5-bromo-5-
chloro-3-indolyl-D-galactoside (x gal) assay. X gal assay is used to obtain another 
qualitative interaction assay. If two proteins are interacting and lacZ gene is expressed, it 
changes x gal from white to green. In our experiment, control A, B stayed white, C had 
slight blue hue, D had blue color, E had deep indigo blue. Transformation 5 and 6 
changed color similar to D.  
 
To quantify our result, we performed chlorophenol red beta D galactopyranoside 
(CPRG) assay. If lacZ gene is expressed, it changes color from yellow to maroon color. 
After color changes, we add stop solution and measure the amount of color change. We 
used FLOUstar Omega Microplate Reader to measure amount of color change. We are 
in progress of analyzing the significance of color change.  
In CPRG assay, we obtained result on Figure 1. 
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Figure 1 Beta Gal Unit in Cav1 and NSP4 Interaction Test  
 
 
After comparing values from Figure 1, we concluded that Cav1 and NSP4 have a weak 
interaction. 
 
Y2H with NSP4 and MID1IP1 
We know from previous data that NSP4 does not interact with Mid1 interacting protein 1 
(MID1IP1) (Parr 2006). NSP4 and MID1IP1 protein interaction was utilized to develop 
the necessary techniques and better understanding of Y2H as negative control. Both 
plasmids were constructed in previous experiment, thus Y2H was performed. 
Transformation of yeast with controls, NSP4 and MID1IP1, was successful as well. 
Using the same Y2H method as with NSP4 and Cav1, we showed successful 
transformations of the yeast (Table 4).  
A B 5-S1 5-S2 5-S3 C D E 
B galactosidase unit 3.24 3.37 9.99 16.11 6.67 22.27 269.69 611.7 
0 
100 
200 
300 
400 
500 
600 
700 
B
e
ta
 G
al
ac
to
si
d
as
e
 U
n
it
 
  18 
Table 4 Transformation Control of NSP4 and MID1IP1 
Transformation Plasmid 1 Plasmid 2 Plate Purpose Results 
1 pDBLeu  None SC-Leu Transformation control 
Growth 
2 None None 
SC-Leu, 
SC-Leu, 
-Trp 
Negative 
transformational 
control 
No growth 
3 pDBLeu Pexp-AD502 
SC-Leu, 
-Trp 
Self activation 
control 
Growth 
4 pD32 MID1IP1 
Pexp-
AD502 
SC-Leu, 
-Trp 
Self activation of 
PDEST32 
Growth 
5 pDBLeu pD22-NSP4 
SC-Leu, 
-Trp 
Self activation of 
pD22-NSP4 
Growth 
6 pD32 MID1IP1 
pD22-
NSP4 
SC-Leu, 
-Trp 
Interaction test 
for pD32-
FKBP4 and 
pD22-NSP4 
Growth 
7 pD32 MID1IP1 None SC-Leu 
Transformational 
control 
Growth 
 
 
Based on the data from Table3, transformation 1 was set as the transformation control 
using the same logic as previously utilized with Y2H analyses of NSP4 and Cav1. After 
incubating for 96 hours, growth was present, confirming success in transformation. 
Transformation 2 served as the negative control for the same reason as previous 
experiments of Y2H with NSP4 and Cav1. After incubating for 96 hours, no growth was 
present, confirming success in transformation. Transformation 3 was positive control for 
same reason as previous experiment on Y2H with NSP4 and Cav1. After incubating for 
96 hours, growth was present, confirming success in transformation. Transformation 4 
was testing activation of pD32 MID1IP1. Yeast was transformed with pD32 MID1IP1 
and Pexp-AD502. Since pD32 MID1IP1 contains pD32 vector, if transformation was 
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successful, yeast will synthesize leu. After incubating for 96 hours in SC without leu and 
trp, growth was present. This confirmed success in transformation. Transformation 5 
was self activation test for same reason as previous experiment on Y2H with NSP4 and 
Cav1. After incubating for 96 hours, no growth was present, confirming success in 
transformation. Transformation 6 was our testing interaction between MID1IP1 and 
NSP4. We transformed yeast with pD32 MID1IP1 and pD22 NSP4. If transformation 
was successful, yeast should synthesize leu and trp itself, thus growth in the plate that 
lacks leu and trp. After incubating for 96 hours, growth was present. This confirmed 
success in transformation. Transformation 7 was set up as another transformation 
control. The yeast was transformed with Pd32 MID1P1. If transformation was 
successful, yeast will synthesize leu and grow in SC that lacks leu. After incubating for 
96 hours, growth was present. This confirmed success in transformation. 
 
To obtain qualitative data to test NSP4 and MID1IP1 interaction, same protocol of NSP4 
and Cav1 was used. In plate SC that lacks leu, trp, and his but contains 12.5mM 3AT, 
50mM 3AT and 100mM 3AT control A, B has no growth, but C and D has little growth 
while E had a lot of growth (As 3AT concentration increased, less growth was 
observed). Transformation 5 and 6 both had no growth.  
 
Transformation 5 and 6 both had no growth. SC that lacks leu, trp, and ura, control A, B 
has no growth, but C and D has little growth while E had a lot of growth. Transformation 
5 and 6 both had growth amount as much as control C. SC that lacks leu, trp, but 
  20 
contains 0.2% 5 fluoroorotic acid (5FOA), control A, B has most growth, but C and D 
has little growth while E had no growth. Transformation 5 and 6 both had growth 
amount as much as B.  
 
In YPAD plate, every sample had great growth. To this plate, we performed 5-bromo-5-
chloro-3-indolyl-D-galactoside (x gal) assay. X gal assay is used to obtain another 
qualitative interaction assay. If two proteins are interacting and lacZ gene is expressed, it 
changes x gal from white to green. In our experiment, control A, B stayed white, C had 
slight blue hue, D had blue color, E had deep indigo blue. Transformation 5 and 6 
changed color similar to A and B.  
 
In CPRG assay, we obtained result on Figure 2. 
 
 
 
Figure 2 Beta Gal Unit in MID1IP1 and NSP4 Interaction Test 
A 5-S1 5-S2 5-S3 B C D E 
Beta gal unit 1.98 0.73 1.35 2.44 1.05 6.11 173.03 352.94 
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After comparing values from Figure 2, we concluded that MID1IP1 and NSP4 does not  
 
interact. 
 
Y2H with NSP4 and FKBP4 
This project is testing the protein protein interaction between NSP4 and FKBP4. The 
NSP4 plasmid was constructed in previous experiments, but we had to construct FKBP4. 
We recombined pD32 vector with FKBP4. The recombination was done by using Not1 
site that are constructed within pD32 vector that has high recombination rate. After 
recombination, we performed the PCR to amplify and sequenced the amplified gene to 
check if FKBP4 has recombined correctly. The sequence result showed that 
recombination was successful. Then Y2H was performed. Transformation of yeast with 
NSP4 and FKBP4 was not successful. Even though we used the same Y2H method as 
with NSP4 and Cav1, we had trouble with growth of yeast in any plate. We also had 
trouble with fungus contamination. In order to eliminate these troubles, we spend 
numerous months to check for media, reagents, yeast stock, lab environment. After 
eliminating all the possible source of error, we were able to continue with Y2H on NSP4 
and FKBP4. (Table 5) 
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Table 5 Transformation of NSP4 and FKBP4 
Transformation Plasmid 1 Plasmid 2 Plate Purpose 
1 pDBLeu  None SC-Leu Growth 
2 None None SC-Leu, SC-Leu, -Trp No Growth 
3 pDBLeu Pexp-AD502 SC-Leu, -Trp Growth 
4 pD32 FKBP4 Pexp-AD502 SC-Leu, -Trp Growth 
5 pDBLeu pD22-NSP4 SC-Leu, -Trp Growth 
6 pD32 FKBP4 pD22-NSP4 SC-Leu, -Trp Growth 
7 pD32 FKBP4 None SC-Leu Growth 
 
 
 
After success of transformation, we plated transformation 5 and 6 colonies with control 
A,B,C,D, and E in selective plates.  
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Table 6 Selective Plate Growth Comparison of NSP4 and FKBP4 Interaction Test 
Selective 
Plate 
A E 5-1 5-2 5-3 5-4 5-5 
-Ura - Most A A A A A 
5FOA - Most C D D D A 
12.5mM 
3AT 
- Most A A A A A 
50Mm 
3AT 
- Most A A A A A 
100Mm 
3AT 
- Most A A A A A 
X-Gal 
No 
change 
Blue 
No 
change 
No 
change 
No 
change 
No 
change 
No 
change 
 
 
 
 
Control A to E, the growth is in gradient. Growth was observed in comparison of control 
CPRG assay is still in progress, but from result in Table 6, we believe there is either no 
interaction or very weak interaction between NSP4 and FKBP4 protein. But we did not 
finish experiment; further study is required for further conclusion. 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
From this experiment, we did verify that Cav1 and NSP4 interacts weakly, because 
selective media experiment confirmed expression of lac Z, Ura 3, and His 3 genes after 
Y2H. We verified that MID1IP1 does not interact with NSP4, confirmed by no 
expression of lac Z, Ura 3, and His 3 gene after Y2H. We are in progress of verifying 
interaction between FKBP4 and NSP4. Due to incomplete data, we cannot conclude 
there is an interaction between these two proteins, but from what we have, FKBP4 and 
NSP4 have very weak or no interaction. 
 
Also from this experience, I have learned how a research laboratory is organized and 
operates the importance of controls, lab notebook and organization. I also learned that 
correct preparation of solutions and media is critical in any experiment and each step 
must be verified. I mastered the technique of preparing of plasmids, performing the 
multi-step Y2H assay, polymerase chain reaction, restriction enzyme digestion, Western 
blot analyses to confirm protein expression. 
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